Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer
新辅助帕博利珠单抗联合化疗治疗非转移性三阴性炎性乳腺癌，达到病理完全缓解
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.106050
Lynce, F; Valenza, C; Niman, S M; Bertucci, F; Kai, M; Ryan, S; Troll, E; Layman, R M; Fanucci, K A; Giordano, A; Nasrazadani, A; Nakhlis, F; Bellon, J; Warren, L; Block, C; Schumer, S; Lucci, A; Krishnamurthy, S; Trapani, D; Lerebours, F; Dalenc, F; Levy, C; Petit, T; Leheurteur, M; Bachelot, T; Tredan, O; Ribeiro, J M; Pistilli, B; Zagami, P; Ladoire, S; Lopez Almeida, L; Zemmour, C; Carey, L A; Tolaney, S M; Valero, V; Curigliano, G; Regan, M M; Goncalves, A; Woodward, W A
